Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 32% ± 11% | |
peripheral blood | 15 studies | 28% ± 9% | |
intestine | 11 studies | 30% ± 16% | |
kidney | 9 studies | 33% ± 8% | |
brain | 9 studies | 33% ± 16% | |
liver | 7 studies | 40% ± 16% | |
eye | 7 studies | 28% ± 11% | |
pancreas | 4 studies | 51% ± 18% | |
bone marrow | 4 studies | 19% ± 4% | |
heart | 4 studies | 17% ± 2% | |
uterus | 4 studies | 40% ± 14% | |
lymph node | 4 studies | 26% ± 14% | |
breast | 4 studies | 26% ± 5% | |
adipose | 4 studies | 31% ± 11% | |
placenta | 3 studies | 24% ± 8% | |
adrenal gland | 3 studies | 21% ± 6% | |
thymus | 3 studies | 42% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4991.07 | 1445 / 1445 | 100% | 44.48 | 183 / 183 |
lung | 100% | 4883.94 | 578 / 578 | 100% | 49.20 | 1155 / 1155 |
ovary | 100% | 5611.09 | 180 / 180 | 100% | 40.56 | 430 / 430 |
prostate | 100% | 5651.03 | 245 / 245 | 100% | 85.61 | 502 / 502 |
brain | 100% | 3865.00 | 2640 / 2642 | 100% | 49.15 | 704 / 705 |
breast | 100% | 6862.37 | 459 / 459 | 100% | 65.30 | 1115 / 1118 |
bladder | 100% | 5140.76 | 21 / 21 | 99% | 48.62 | 501 / 504 |
kidney | 100% | 7857.36 | 89 / 89 | 99% | 58.43 | 895 / 901 |
stomach | 100% | 5835.29 | 359 / 359 | 99% | 49.72 | 284 / 286 |
intestine | 100% | 7245.20 | 966 / 966 | 99% | 49.77 | 523 / 527 |
liver | 100% | 29003.99 | 226 / 226 | 99% | 123.26 | 402 / 406 |
uterus | 100% | 4669.61 | 170 / 170 | 99% | 46.41 | 454 / 459 |
thymus | 100% | 5388.65 | 653 / 653 | 99% | 50.15 | 597 / 605 |
pancreas | 99% | 3383.88 | 326 / 328 | 99% | 53.43 | 176 / 178 |
adrenal gland | 100% | 6115.08 | 258 / 258 | 97% | 27.52 | 222 / 230 |
skin | 100% | 4982.99 | 1807 / 1809 | 96% | 32.55 | 452 / 472 |
adipose | 100% | 6995.61 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5633.38 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 28.92 | 29 / 29 |
spleen | 100% | 2884.59 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.59 | 1 / 1 |
muscle | 100% | 4539.16 | 802 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 36.02 | 44 / 45 |
heart | 96% | 4614.62 | 830 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 83% | 2196.92 | 769 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 78% | 18.10 | 62 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008206 | Biological process | bile acid metabolic process |
GO_0015914 | Biological process | phospholipid transport |
GO_0032385 | Biological process | positive regulation of intracellular cholesterol transport |
GO_0032367 | Biological process | intracellular cholesterol transport |
GO_1901373 | Biological process | lipid hydroperoxide transport |
GO_0036109 | Biological process | alpha-linolenic acid metabolic process |
GO_0006699 | Biological process | bile acid biosynthetic process |
GO_0006635 | Biological process | fatty acid beta-oxidation |
GO_0033540 | Biological process | fatty acid beta-oxidation using acyl-CoA oxidase |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005777 | Cellular component | peroxisome |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005782 | Cellular component | peroxisomal matrix |
GO_0003988 | Molecular function | acetyl-CoA C-acyltransferase activity |
GO_0033814 | Molecular function | propanoyl-CoA C-acyltransferase activity |
GO_0015485 | Molecular function | cholesterol binding |
GO_0050632 | Molecular function | propionyl-CoA C2-trimethyltridecanoyltransferase activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0050633 | Molecular function | acetyl-CoA C-myristoyltransferase activity |
GO_0036042 | Molecular function | long-chain fatty acyl-CoA binding |
GO_0000062 | Molecular function | fatty-acyl-CoA binding |
GO_0070538 | Molecular function | oleic acid binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SCP2 |
Protein name | Alternative protein SCP2 Sterol carrier protein 2 Sterol carrier protein 2 (SCP-2) (Acetyl-CoA C-myristoyltransferase) (EC 2.3.1.155) (Non-specific lipid-transfer protein) (NSL-TP) (Propanoyl-CoA C-acyltransferase) (EC 2.3.1.176) (SCP-2/3-oxoacyl-CoA thiolase) (SCP-2/thiolase) (EC 2.3.1.16) (SCP-chi) (SCPX) (Sterol carrier protein X) (SCP-X) propanoyl-CoA C-acyltransferase (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) |
Synonyms | |
Description | FUNCTION: [Isoform SCPx]: Plays a crucial role in the peroxisomal oxidation of branched-chain fatty acids . Catalyzes the last step of the peroxisomal beta-oxidation of branched chain fatty acids and the side chain of the bile acid intermediates di- and trihydroxycoprostanic acids (DHCA and THCA) . Also active with medium and long straight chain 3-oxoacyl-CoAs. Stimulates the microsomal conversion of 7-dehydrocholesterol to cholesterol and transfers phosphatidylcholine and 7-dehydrocholesterol between membrances, in vitro (By similarity). Isoforms SCP2 and SCPx cooperate in peroxisomal oxidation of certain naturally occurring tetramethyl-branched fatty acyl-CoAs (By similarity). .; FUNCTION: [Isoform SCP2]: Mediates the transfer of all common phospholipids, cholesterol and gangliosides from the endoplasmic reticulum to the plasma membrane. May play a role in regulating steroidogenesis . Stimulates the microsomal conversion of 7-dehydrocholesterol to cholesterol (By similarity). Also binds fatty acids and fatty acyl Coenzyme A (CoA) such as phytanoyl-CoA. Involved in the regulation phospholipid synthesis in endoplasmic reticulum enhancing the incorporation of exogenous fatty acid into glycerides. Seems to stimulate the rate-limiting step in phosphatidic acid formation mediated by GPAT3. Isoforms SCP2 and SCPx cooperate in peroxisomal oxidation of certain naturally occurring tetramethyl-branched fatty acyl-CoAs (By similarity). . |
Accessions | H0YEU8 H0YF61 ENST00000478274.6 ENST00000371514.8 [P22307-1] ENST00000488965.1 [P22307-5] P22307 ENST00000408941.7 [P22307-5] ENST00000478631.6 ENST00000528311.5 [P22307-4] ENST00000533119.1 H0YCB0 ENST00000484100.5 ENST00000435345.6 [P22307-2] E9PLD1 H0YD06 ENST00000371509.8 [P22307-7] L0R5C7 ENST00000407246.6 [P22307-8] ENST00000529363.2 ENST00000430330.6 [P22307-6] ENST00000371513.9 [P22307-3] |